Ken Tajima
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Occupational and environmental lung diseases 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Oncology 12
- Cancer Cells and Metastasis 3
- Co-authors
- Kazuhisa Takahashi (30 shared papers)Fumiyuki Takahashi (23 shared papers)Shin‐ichiro Iwakami (8 shared papers)Shyamala Maheswaran (5 shared papers)Fariz Nurwidya (6 shared papers)Muneaki Hashimoto (5 shared papers)Takeshi Nara (5 shared papers)Naoko Shimada (8 shared papers)
- Journals
- Nature Communications (2 papers)BMC Cancer (2 papers)Oncogene (2 papers)Lung Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ken Tajima
39 papers receiving 937 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 211
- Oncology 270
- Pulmonary and Respiratory Medicine 259
- Molecular Biology 456
- Rheumatology 59
Countries citing papers authored by Ken Tajima
This map shows the geographic impact of Ken Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Tajima more than expected).
Fields of papers citing papers by Ken Tajima
This network shows the impact of papers produced by Ken Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Tajima. The network helps show where Ken Tajima may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Tajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 106 | |
| 2 | 2011 | 82 | |
| 3 | 2013 | 78 | |
| 4 | 2012 | 57 | |
| 5 | 2011 | 50 | |
| 6 | 2016 | 45 | |
| 7 | 2009 | 43 | |
| 8 | 2019 | 43 | |
| 9 | 2019 | 42 | |
| 10 | 2010 | 42 | |
| 11 | 2015 | 40 | |
| 12 | 2008 | 39 | |
| 13 | 2013 | 30 | |
| 14 | 2022 | 24 | |
| 15 | 2018 | 21 | |
| 16 | 2020 | 21 | |
| 17 | Distinct roles of cholinergic receptors in small cell lung cancer cells. | 2010 | 18 |
| 18 | Osteopontin modulates malignant pleural mesothelioma cell functions in vitro. | 2009 | 16 |
| 19 | 2001 | 15 | |
| 20 | 2023 | 13 |
About Ken Tajima
Ken Tajima is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Rheumatology and Epidemiology, having authored 39 papers that have together received 948 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Bone and Dental Protein Studies (5 papers), Occupational and environmental lung diseases (4 papers), Epigenetics and DNA Methylation (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (211 citations), Oncology (270 citations), Pulmonary and Respiratory Medicine (259 citations), Molecular Biology (456 citations) and Rheumatology (59 citations). Ken Tajima has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Shin‐ichiro Iwakami, Shyamala Maheswaran, Fariz Nurwidya, Muneaki Hashimoto, Takeshi Nara, Naoko Shimada, Isao Kobayashi and Hiroyuki Moriyama. Their work appears in journals such as Nature Communications, BMC Cancer, Oncogene, Lung Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.